Publication Name	World Journal of Clinical Cases
Manuscript ID	96823
Country	Taiwan

Received	2024-05-15 22:47
Peer-Review Started	2024-05-15 22:48
To Make the First Decision
Return for Revision	2024-08-23 16:57
Revised	2024-09-02 18:25
Second Decision	2024-09-09 02:48
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-09-09 10:30
Articles in Press	2024-09-09 10:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-09-11 08:50
Publish the Manuscript Online	2024-10-24 09:16

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Advancing oral cancer care: Insights from Tongluo Jiedu prescription
Manuscript Source	Invited Manuscript
All Author List	Chun-Yao Cheng, Wen-Rui Hao, Ju-Chi Liu and Tzu-Hurng Cheng
Funding Agency and Grant Number
Corresponding Author	Tzu-Hurng Cheng, PhD, Professor, Department of Biochemistry, School of Medicine, College of Medicine, China Medical University, No. 91 Xueshi Road, North District, Taichung 404328, Taiwan. thcheng@mail.cmu.edu.tw
Key Words	Tongluo Jiedu prescription; Oral cancer patients; Immune function; Oxidative stress; Traditional Chinese medicine; Adjunctive therapy
Core Tip	The study provides valuable insights into the effectiveness of the Tongluo Jiedu prescription as an adjunctive therapy in oral cancer management. By prospectively evaluating immune function and oxidative stress levels in patients with oral cancer receiving Tongluo Jiedu prescription alongside conventional chemotherapy, the study highlighted the potential of traditional Chinese medicine in enhancing patient outcomes. The findings suggest that the Tongluo Jiedu prescription could be a valuable complementary approach to reduce treatment-related complications and accelerate recovery in oral cancer care.
Publish Date	2024-10-24 09:16
Citation	<p>Cheng CY, Hao WR, Liu JC, Cheng TH. Advancing oral cancer care: Insights from Tongluo Jiedu prescription. <i>World J Clin Cases</i> 2024; 12(35): 6764-6769</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i35/6764.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i35.6764

Full Article (PDF)	WJCC-12-6764-with-cover.pdf
Manuscript File	96823_Auto_Edited_030212.docx
Answering Reviewers	96823-answering-reviewers.pdf
Audio Core Tip	96823-audio.mp3
Conflict-of-Interest Disclosure Form	96823-conflict-of-interest-statement.pdf
Copyright License Agreement	96823-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	96823-non-native-speakers.pdf
Peer-review Report	96823-peer-reviews.pdf
Scientific Misconduct Check	96823-scientific-misconduct-check.png
Scientific Editor Work List	96823-scientific-editor-work-list.pdf
CrossCheck Report	96823-crosscheck-report.pdf